- Sold by Iktos
Forget about screening, start designing your next molecules with Generative AI Makya platform. Iktos keeps developing its proprietary and innovative generative AI solution which enables, using existing data, to design molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical Research and Development.